CRISPR/Cas9 genome-wide loss-of-function screening identifies druggable cellular factors involved in sunitinib resistance in renal cell carcinoma

Peter Makhov(Fox Chase Cancer Center), Vladimir Kolenko(Fox Chase Cancer Center)
British Journal of Cancer
September 24, 2020
Cited by 28


Related Papers